Adrenocorticotropic Hormone
"Adrenocorticotropic Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP).
Descriptor ID |
D000324
|
MeSH Number(s) |
D06.472.699.327.935.531.500 D06.472.699.631.525.600.531.500 D12.644.400.400.935.531.500 D12.644.548.365.935.531.500 D12.644.548.691.525.690.531.500 D12.776.631.650.405.935.531.500
|
Concept/Terms |
Adrenocorticotropic Hormone- Adrenocorticotropic Hormone
- Hormone, Adrenocorticotropic
- ACTH (1-39)
- ACTH
- Corticotrophin
- Corticotropin
- Corticotropin (1-39)
- Corticotrophin (1-39)
- Adrenocorticotrophic Hormone
- Hormone, Adrenocorticotrophic
- 1-39 ACTH
- Adrenocorticotropin
|
Below are MeSH descriptors whose meaning is more general than "Adrenocorticotropic Hormone".
Below are MeSH descriptors whose meaning is more specific than "Adrenocorticotropic Hormone".
This graph shows the total number of publications written about "Adrenocorticotropic Hormone" by people in this website by year, and whether "Adrenocorticotropic Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 | 1998 | 0 | 1 | 1 | 1999 | 0 | 3 | 3 | 2000 | 0 | 1 | 1 | 2001 | 1 | 0 | 1 | 2002 | 1 | 0 | 1 | 2003 | 0 | 2 | 2 | 2004 | 2 | 5 | 7 | 2005 | 1 | 3 | 4 | 2006 | 2 | 2 | 4 | 2007 | 0 | 3 | 3 | 2008 | 1 | 1 | 2 | 2009 | 2 | 1 | 3 | 2010 | 1 | 4 | 5 | 2011 | 1 | 4 | 5 | 2012 | 0 | 2 | 2 | 2013 | 0 | 3 | 3 | 2014 | 1 | 3 | 4 | 2015 | 2 | 0 | 2 | 2016 | 3 | 3 | 6 | 2017 | 0 | 2 | 2 | 2018 | 0 | 2 | 2 | 2019 | 1 | 1 | 2 | 2020 | 1 | 2 | 3 | 2021 | 1 | 2 | 3 | 2022 | 0 | 2 | 2 | 2023 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenocorticotropic Hormone" by people in Profiles.
-
Newfield RS, Sarafoglou K, Fechner PY, Nokoff NJ, Auchus RJ, Vogiatzi MG, Jeha GS, Giri N, Roberts E, Sturgeon J, Chan JL, Farber RH. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2023 10 18; 108(11):2871-2878.
-
Bennett JL, Grove NC, Johnson RK, Mizenko C, DuPont JC, Wagner BD, Lynch AM, Frohman TC, Shindler KS, Frohman EM. A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone for Neuroprotection in Acute Optic Neuritis. J Neuroophthalmol. 2023 09 01; 43(3):323-329.
-
Olson HE, Demarest S, Pestana-Knight E, Moosa AN, Zhang X, P?rez-P?rez JR, Weisenberg J, O'Connor Prange E, Marsh ED, Rajaraman RR, Suter B, Katyayan A, Haviland I, Daniels C, Zhang B, Greene C, DeLeo M, Swanson L, Love-Nichols J, Benke T, Harini C, Poduri A. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies. Epilepsia. 2023 07; 64(7):1821-1832.
-
Barcomb K, Olah SS, Kennedy MJ, Ford CP. Properties and modulation of excitatory inputs to the locus coeruleus. J Physiol. 2022 11; 600(22):4897-4916.
-
Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2022 02 17; 107(3):801-812.
-
Demarest S, Calhoun J, Eschbach K, Yu HC, Mirsky D, Angione K, Shaikh TH, Carvill GL, Benke TA. Whole-exome sequencing and adrenocorticotropic hormone therapy in individuals with infantile spasms. Dev Med Child Neurol. 2022 05; 64(5):633-640.
-
Wellman K, Fu R, Baldwin A, Rege J, Murphy E, Rainey WE, Mukherjee N. Transcriptomic Response Dynamics of Human Primary and Immortalized Adrenocortical Cells to Steroidogenic Stimuli. Cells. 2021 09 09; 10(9).
-
Xia L, Shen D, Zhang Y, Lu J, Wang M, Wang H, Chen Y, Xue D, Xie D, Li G. Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells. J Cell Mol Med. 2021 03; 25(5):2404-2417.
-
Grinspan ZM, Mytinger JR, Baumer FM, Ciliberto MA, Cohen BH, Dlugos DJ, Harini C, Hussain SA, Joshi SM, Keator CG, Knupp KG, McGoldrick PE, Nickels KC, Park JT, Pasupuleti A, Patel AD, Pomeroy SL, Shahid AM, Shellhaas RA, Shrey DW, Singh RK, Wolf SM, Yozawitz EG, Yuskaitis CJ, Waugh JL, Pearl PL. Crisis Standard of Care: Management of Infantile Spasms during COVID-19. Ann Neurol. 2020 08; 88(2):215-217.
-
Messer R, Knupp KG. Infantile Spasms: Opportunities to Improve Care. Semin Neurol. 2020 04; 40(2):236-245.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|